GSK publishes vaccine trial records for mother and baby homes
The enhanced service will also include a “more simplified information request service,” the company said.
GlaxoSmithKline (GSK) is to offer an “enhanced information service” for former residents of mother and baby homes regarding trials it engaged in between 1934 and 1973.
The company said it was offering the service in response to issues raised following the publication of the Commission of Investigation’s report.
